Literature DB >> 2821766

L-651,392: a novel, potent and selective 5-lipoxygenase inhibitor.

Y Guindon1, Y Girard, A Maycock, A W Ford-Hutchinson, J G Atkinson, P C Bélanger, A Dallob, D DeSousa, H Dougherty, R Egan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2821766

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Leukot Res        ISSN： 0732-8141


× No keyword cloud information.
  5 in total

1.  Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway.

Authors:  J D Lundgren; M Kaliner; C Logun; J H Shelhamer
Journal:  Agents Actions       Date:  1990-06

2.  L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis.

Authors:  M Tardif; D Beauchamp; Y Bergeron; C Lessard; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

3.  The effect of non-steroidal anti-inflammatory drugs on the accumulation and release of interleukin-1-like activity by peritoneal macrophages from the mouse.

Authors:  A K Bahl; M M Dale; J C Foreman
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

4.  Mesangial cell immune injury. Hemodynamic role of leukocyte- and platelet-derived eicosanoids.

Authors:  B A Bresnahan; S Wu; F J Fenoy; R J Roman; E A Lianos
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

5.  Effect of manoalide on human 5-lipoxygenase activity.

Authors:  F Cabré; A Carabaza; N Suesa; A M García; E Rotllan; M Gómez; D Tost; D Mauleón; G Carganico
Journal:  Inflamm Res       Date:  1996-05       Impact factor: 4.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.